RO7790121, RO7790121 Placebo
GA45332
Phase 3 small_molecule active
Quick answer
RO7790121, RO7790121 Placebo for Moderately to Severely Active Crohn's Disease (CD) is a Phase 3 program (small_molecule) at Roche Registration Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Roche Registration Limited
- Indication
- Moderately to Severely Active Crohn's Disease (CD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active